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Objective: Infrapatellar fat pad of patients with osteoarthritis (OA) contains multipotent and highly
clonogenic adipose-derived stem cells that can be isolated by low invasive methods. Moreover, nuclear
and cytoplasmic cellular extracts have been showed to be effective in induction of cell differentiation and
reprogramming. The aim of this study was to induce chondrogenic differentiation of autologous
mesenchymal stem cells (MSCs) obtained from infrapatellar fat pad (IFPSCs) of patients with OA using
cellular extracts-based transdifferentiation method.
Design: IFPSCs and chondrocytes were isolated and characterized by ﬂow cytometry. IFPSCs were per-
meabilized with Streptolysin O and then exposed to a cell extract obtained from chondrocytes. Then,
IFPSCs were cultured for 2 weeks and chondrogenesis was evaluated by morphologic and ultrastructural
observations, immunologic detection, gene expression analysis and growth on 3-D poly (DL-lactic-co-
glycolic acid) (PLGA) scaffolds.
Results: After isolation, both chondrocytes and IFPSCs displayed similar expression of MSCs surface
makers. Collagen II was highly expressed in chondrocytes and showed a basal expression in IFPSCs. Cells
exposed to chondrocyte extracts acquired a characteristic morphological and ultrastructural chondrocyte
phenotype that was conﬁrmed by the increased proteoglycan formation and enhanced collagen II im-
munostaining. Moreover, chondrocyte extracts induced an increase in mRNA expression of chondrogenic
genes such as Sox9, L-Sox5, Sox6 and Col2a1. Interestingly, chondrocytes, IFPSCs and transdifferentiated
IFPSCs were able to grow, expand and produce extracellular matrix (ECM) on 3D PLGA scaffolds.
Conclusions:We demonstrate for the ﬁrst time that extracts obtained from chondrocytes of osteoarthritic
knees promote chondrogenic differentiation of autologous IFPSCs. Moreover, combination of trans-
differentiated IFPSCs with biodegradable PLGA 3D scaffolds can serve as an efﬁcient system for the
maintenance and maturation of cartilage tissue. These ﬁndings suggest its usefulness to repair articular
surface in OA.
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Chondral defects suppose a challenging clinical problem
aggravated by the increase in elderly population in developed
countries. Consequently, many strategies including arthroplasty,
the stimulation of reparative tissues through arthroscopic, abra-
sion, drilling or microfracture1 have been developed to treat the
injured cartilage. However, these procedures cannot reproduce
successfully the tissue characteristics of hyaline cartilage2,3. New
biological based strategies such as the replacement of damagedublished by Elsevier Ltd. All rights reserved.
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of cultured expanded autologous chondrocytes have been used for
cartilage repair5. Nevertheless, the difﬁculties to obtain sufﬁcient
amounts of autologous chondrocytes6 or the dedifferentiation
process that chondrocytes undergo after serial passages in mono-
layer culture7 are the main disadvantages that limit their use.
MSCs represent an attractive cell source for cartilage regenera-
tion cell therapy approach. These multipotent cells can be easily
isolated from different sources such as bone marrow, fat tissue,
umbilical cord or peripheral blood among others8 and present
a high proliferation capacity. The chondrogenic potential of MSCs
derived from bone marrow have been demonstrated; 9 however,
the extraction procedure is invasive and increases morbidity in
patients with osteochondral disease. Therefore, it is necessary to
search new sources of MSCs that could be isolated by less invasive
methods. In this respect, MSCs obtained from adipose tissue
represent a good alternative and recently, it has been shown that
Hoffa’s fat pad in patients with osteoarthritis (OA), contains mul-
tipotent and highly clonogenic adipose-derived stem cells10,11.
These cells can be obtained from the articulation of the patient in
a single surgical procedure12,13.
Last years, many protocols for inducing adult stem cells to
differentiate in vitro across germinal boundaries, a process referred
to as transdifferentiation, has been described14e16. There are
different strategies for achieving adult cell reprogramming or
transdifferentiation: somatic nuclear transfer, cell fusion, ectopic
expression of master switch genes and cell extract based
methods17. The use of nuclear and cytoplasmic extracts has been
showed to be effective in induction of cell differentiation and cell
reprogramming18,19. Among potential beneﬁts of the extract
approach are the use of autologousmaterial to direct differentiation
and to avoid exogenous genes, recombinant proteins like exoge-
nous growth factors or viral delivery methods.
In this study, we used cellular extracts-based trans-
differentiation method to induce chondrogenic differentiation of
autologous MSCs obtained from infrapatellar fat pad (IFPSCs) of
patients with OA. Here, we demonstrate for the ﬁrst time, that
IFPSCs can undergo chondrogenesis when stimulated with an
extract prepared from autologous chondrocytes obtained from
patients’ cartilage tissue.
Materials and methods
Patients
Both human IFPSCs and articular cartilage were obtained from
18 patients with knee OA during joint replacement surgery. Ethical
approval for the study was obtained from the Ethics Committee of
the Clinical University Hospital of Málaga, Spain. Informed patient
consent was obtained for all samples used in this study. None of the
patients had a history of inﬂammatory arthritis or crystal-induced
arthritis. Human articular cartilage was obtained from the
femoral side, selecting the non-overload compartment: lateral
condyle in varus knees andmedial condyle in the valgus cases. Only
cartilage that macroscopically looked relatively normal was used
for this study. Hoffa’s fat pad was harvested from the interior of the
capsule excluding vascular areas and synovial regions. Samples
collected at joint arthroplasty were transported to the laboratory in
Dulbecco’s modiﬁed Eagle’s medium (DMEM; Sigma, St. Louis, MO,
USA) with 100 U/ml penicillin and 100 mg/ml streptomycin.
Isolation of human articular chondrocytes
Articular cartilage was minced and digested overnight in an
overnight 0.08% collagenase IV (Sigma) digestion at 37C withgentle agitation. Cells were centrifuged and rinsing to remove the
collagenase. The remaining cells were then plated in cultured ﬂasks
with chondrocytes media:DMEM (Sigma) supplemented with 20%
FBS (Lonza, Basel, Switzerland), 7 ml human insulin (Actrapid;
Novo Nordisk, Bagsvaerd, Denmark), 6 ml DNase I (Sigma), 100 U/ml
penicillin and 100 mg/ml streptomycin at 37C in a humidiﬁed
atmosphere of 5% CO2. After 24 h the medium was replaced with
fresh medium supplemented with 10% FBS. Chondrocytes were
cultured for a maximum of 3 weeks before the experiments to
avoid dedifferentiation phenomenon7.
Isolation of MSCs from IFPSCs
Fat tissue ﬁnely minced was digested using enzymatic solution
of 1 mg/ml collagenase type IA (Sigma) and incubated on a shaker
at 37C for 1 h. After digestion, collagenase was removed by a single
wash in sterile phosphate-buffered saline (PBS), followed by two
further washes in DMEM supplemented with 10% FBS. The cell
pellet was resuspended in DMEM (Sigma) containing 10% FBS and
1% penicillin/streptomycin, added to tissue culture ﬂasks, and
cultured at 37C in 5% CO2. After 48 h the mediumwas removed to
discard non-adherent cells. At 80% of conﬂuency the cells were
released with trypsineethylenediaminetetraacetic acid (EDTA)
(Sigma) and subcultured.
Characterization of articular chondrocytes and IFPSCs
The immunophenotype of articular chondrocytes and cultured
IFPSCs was analyzed by ﬂow cytometry (FACS). MSC marker phe-
notyping was performed as previously described20. For the deter-
mination of collagen II expression cells were, ﬁrst, ﬁxed and
permeabilized with Fix and Perm reagent (Invitrogen, Carlsbad,
CA, USA), then incubated with the primary monoclonal antibody
(AbCam, Cambridge, UK) for 20 min, washed and ﬁnally incubated
with a secondary FITC-conjugate monoclonal antibody (Sigma) for
30 min. All cells were washed in PBS and analyzed in a FACSCanto II
cytometer (BD Biosciences).
Differentiation assays of IFPSCs
Human IFPSCs were plated at 2  103 cells/cm2 in DMEM
(Sigma) containing 10% FBS with penicillin and streptomycin at
100 mg/ml and allowed to adhere for 24 h. The culture mediumwas
then replaced with speciﬁc inductive media to demonstrate adi-
pogenic, osteogenic and chondrogenic differentiation potential as
previously reported20. In brief, for adipogenic, osteogenic and
chondrogenic differentiation, cells were cultured for 2 weeks in
Adipogenic MSCs Differentiation BulletKit, Osteogenic MSCs
Differentiation BulletKit (Lonza, Basel, Switzerland) and NH Chon-
droDiff Medium (Miltenyi Biotec, Auburn, CA, USA), respectively.
Cell permeabilization assay and exposure to cell extract of IFPSCs
Prior IFPSCs incubation with the nuclear and cytoplasmic
extracts, the efﬁciency of Streptolysin O (SLO; Sigma) treatmentwas
evaluated following a modiﬁcation of the protocol described in21.
Brieﬂy, 3  105 IFPSCs were permeabilized with several concen-
tration of SLO and exposed to Texas red-conjugated 70,000 Mr
dextran (Invitrogen). The uptake of the dye was observed by phase
contrast and epiﬂuorescence microscopy after 2 h and 24 h of SLO
permeabilization. Chondrocytes extract preparation and exposure
to IFPSCs were performed as described elsewhere22 with slight
modiﬁcations (See Supplementary data). 1,666 chondrocytes per
1,000 IFPSCs were used per reaction. After in vitro reprogramming
in cellular extracts, cells were cultured for 2 weeks until use. We
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viabilitywas assessed by phase contrastmicroscopy after 2weeks of
extract exposure by counting cells in four different regions of the
dish and calculating the average.
Transmission electron microscopy (TEM)
Cells were assayed for by TEM as previously reported17 and
sections were examined with a LEO 906E transmission electron
microscope.
Histological and immunohystochemical analysis
Cells seeded on glass coverslips and cell-seeded poly (DL-lactic-
co-glycolic acid) (PLGA) sections were assayed for cartilaginous
matrix production by toluidine blue and safranin O staining. Type II
collagen expression was determined by immunoﬂuorescence as
previously described17. A primary monoclonal antibody anti-
collagen type II (Santa Cruz Biotechnology, Santa Cruz, CA, USA)was
used and photographs were taken with a Leica DM 5500B (Solms,
Germany) ﬂuorescent microscope, software Meta Systems Isis.
Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA from control SLO-permeabilized cells, SLO-per-
meabilized cells exposed to the extract and from cultured chon-
drocytes (positive control) was extracted using TriReagent (Sigma).
RNA was reverse transcribed using the Reverse Transcription
System kit (Promega, Madison, WI, USA) and the PCR reaction was
performedwith ReddyMix PCRMaster Mix (Thermo,Waltham,MA,
USA). After the initial denaturation (2 min at 94C), 33 cycles were
performed (30 s at 94C, 50 s for annealing temperature and 1 min
at 72C) for all set of primers except for b-actin, which was 25
cycles. Primer sequences and annealing temperatures can be found
in Table I. The PCR products were visualized on 1% agarose gels
containing 0.1 mg/ml ethidium bromide using ultraviolet light.
In vitro primary culture on scaffold
We used a biodegradable cylindrical implant constructed of
a porous cartilage phase and a porous bone phase (5 mm in
diameter  10 mm deep). The cartilage phase of the scaffold was
cut to 3 mm in diameter and 3 mm in height under sterile condi-
tions on a Petri dish and was plated in 96-well plates. The synthetic
material is a blend of poly DL-lactide-co-glycolide, polyglycolide
ﬁbers and surfactant (TruFit CB Plug; Smith & Nephew, London,Table I
Sequences of the primers used in the RT-PCR reactions
Target gene Primers (forward and reverse)
Collagen type I GAG AGC ATG ACC GAT GG
GTG ACG CTG TAG GTG AA
Collagen type II GAC AAT CTG GCT CCC AAC
ACA GTC TTG CCC CAC TTA C
Collagen type X GCC CAC TAC CCA ACA C
TGG TTT CCC TAC AGC TGA
Aggrecan I GTC TCA CTG CCC AAC TAC
GGA ACA CGA TGC CTT TCA C
Sox-5 ATC CCA ACT ACC ATG GCA GCT
GAT ACC TGC ATT GCA GCT
Sox-6 GCA GTG ATC AAC ATG TGG CCT
TTC ATC ATG CGCTGC CAG TAG
Sox-9 GAG CAG ACG CAC ATC TC
CCT GGG ATT GCC CCG A
Gapdh GAA GGT GAA GGT CGG AGT C
GAA GAT GGT GAT GGG ATT TCUK). Cells suspensions containing 6,000 cells in 50 ml of medium
were slowly dropped onto the surface of each scaffold incubated in
96-well plates for 4 h at 37C and then analyzed under the inverted
microscope to check cell adhesion to the polymer surface. After
that, 50 ml of fresh medium was added in each well plate. Cell
culture medium was changed every 2 days.
Environmental scanning electron microscope (ESEM) analysis
After 3 days of culture, samples were ﬁxed in 3% glutaraldehyde
during 2 h at 4C and then were rinsed several times with sodium
cacodylate. The samples were kept refrigerated into PBS. The obser-
vations started at an initial water vapor pressure of 5.7 tors. At this
pressure, a liquid water phase was present in the sample (100% RH).
Then, vapor pressure was decreasing slowly until the surfaces of the
samples were visible (4.5 and 5 tors). Accelerating voltages varied
between 10 and 15 kV we obtained a good image resolution using
small beam current (spot size 3e3.5) and a working distance of 5e
6 mm. The ESEM used in this work was a Quanta 400 (FEI) located at
the Centro de Instrumentación Cientíﬁca of the University of Granada.
Results
Cell isolation and characterization of chondrocytes
FACS characterization showed that ex-vivo cultured chon-
drocytes expressed the surface markers CD73 (99.84%), CD90
(97.25%) CD105 (99.74%) and the intracellular protein collagen type
II (60%), while lacked expression for both hematopoietic and
endothelial cell markers CD45 (<1%), CD34 (1.4%), CD133 (1.82%),
CXCR4 (2.27%), KDR (7.63%) [Fig. 1(A)].
Light microcopy observation showed that chondrocytes at day
one were attached to the ﬂask surface as cell-clusters of rounded
shapes [Fig. 1(B)]. After a week in culture, cells displayed a polyg-
onal shape appearing some of them with a star-like morphology
[Fig. 1(C)]. These stellated-like cells occupied the entire surface and
reached conﬂuence after 2 weeks [Fig. 1(D)].
Cell isolation and characterization of IFPSCs
Isolated IFPSCs presented a spindle shape ﬁbroblastic
morphology. FACS characterization demonstrated a positive
expression of the surface markers CD73 (>99.80%), CD90
(>99.42%), CD105 (>99.91%) and a negative expression for CD45
(1.16%), CD34 (8.16%), CD133 (1.41%), CXCR4 (1.97%) and KDR
(1.49%) as shown previously23. In addition, IFPSCs showed a slightly
expression of collagen type II (13%) [Fig. 2(A)]. IFPSCs treated with
conditioned media displayed characteristics of adipogenic, osteo-
genic and chondrogenic differentiation after staining [Fig. 2(B)].
Cell permeabilization assay
Previous to perform the extract reprogramming experiment we
optimize IFPSCs permeabilization procedure by testing different
concentrations of the SLO toxin ranged from 0.230e305 ng/ml.
Among the tested concentration, 185 ng/ml of SLO was the most
efﬁcient, permeabilizing 80e95% of the cells [Fig. 3]. Results showed
that 20e25% of the cells survived to the extract exposurewhile 80% of
control cells (permeabilized but not exposed to extract) were viable.
Phenotypic changes after exposition to chondrocyte extracts
Phase microscopy observation of cultured chondrocytes showed
a typical polygonal morphology with a high rate of star-like cells
[Fig. 4(A)]. On the other hand, permeabilized but not exposed to
Fig. 1. Phenotypic characterization of chondrocytes. (A) Chondrocytes were cultured for 2 weeks and then tested for mesenchymal surface markers (CD105, CD73 and CD90),
hematopoietic and endothelial markers (CD133, CD34, KDR, CD45 and CXCR4) and for collagen II by ﬂow cytometry. White histograms identify the isotype controls (negative). (Be
D) Phase-contrast light microscopy of cultured human articular chondrocytes for 1 (B), 7 (C) and 14 days (D). Original magniﬁcation: 10 for B and 20 for C and D.
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chymal shape consisting in ﬂatter cells with a spindle-like
morphology [Fig. 4(B)]. It can be appreciated that IFPSCs acquired
a chondrocyte-like phenotype after exposure to the autologous cell
extract, showing an increased number of smaller polygonal and
star-shaped cells [Fig. 4(C)].
Furthermore, toluidine blue assay demonstrated a characteristic
positive metachromatic staining in both chondrocytes and IFPSCs
treated with extracts which evidenced the synthesis of glycos-
aminoglycans (GAGs) [Fig. 4(D and F), respectively] when compared
with control cells [Fig. 4(E)].
Ultrastructural analysis
TEM showed that cultured chondrocytes possessed an
euchromatic nuclei, a cytoplasm rich in rough endoplasmicreticulum (RER), many transport vesicles, lipid droplets (LI) and
proteoglycan granules. Moreover, ECM produced by cultured
chondrocytes contained a homogeneous population of ﬁbrillar
collagens (FC) with typical striation [Fig. 4(G and J)]. Control
IFPSCs exhibited morphological features typical of MSCs, including
various mitochondrial proﬁles, small vacuoles and a nucleus with
multiple nucleoli [Fig. 4(H and K)]. In contrast, extract exposed
IFPSCs seemed to have undergone chondrogenic differentiation
characterized by nuclei with prominent nucleoli, extended cistern
of RER, Golgi apparatus (GA) and vacuoles and ﬁne cytoplasmatic
processes [Fig. 4(I and L)]. Moreover, a characteristic feature
present in chondrocytes and found in extract exposed IFPSCs
[Fig. 4(I and L)], but not in control [Fig. 4(H and K)], was the
presence of proteoglycan granules in both cytoplasm and ECM.
Round-shaped lipid vesicles of variable size were also present in
differentiated cells.
Fig. 2. Phenotypic characterization and differentiation potential of IFPSCs. (A) IFPSCs were cultured for 2 weeks and then tested for mesenchymal surface markers (CD105, CD73 and
CD90), hematopoietic and endothelial markers (CD133, CD34, KDR, CD45 and CXCR4) and for collagen II by ﬂow cytometry. (B) The differentiation potential of IFPSCs towards
adipogenic, chondrogenic and osteogenic lineage was conﬁrmed by Oil Red O, toluidine blue and Alizarin Red S staining, respectively. Upper pictures show negative controls, cells
cultured in normal medium for 2 weeks and then histochemically stained. Original magniﬁcation: 10.
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Fig. 3. Reversible cell permeabilization, uptake of a Texas red-conjugated dextran by IFPSCs. Intact IFPSC (SLO) or SLO-permeabilized IFPSC (þSLO). Cells were incubated for
30 min in HBSS containing 50 mg/ml of Texas red-conjugated 70,000 Mr dextran, resealed with 2 mM CaCl2 and cultured for 2 h and 24 h before observation by phase contrast and
epiﬂuorescence microscopy. Original magniﬁcation: 10 for AeD and 20 for EeF.
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markers
After 2 weeks of exposure to extracts, we analyzed the expres-
sion of collagen II by immunoﬂuorescence. Extract exposed IFPSCs
[Fig. 5(C, F and I)] showed a strong expression of collagen II protein
with a similar pattern of cultured chondrocytes [Fig. 5(A, D and G)].
Collagen type II was conﬁned in both cytoplasm and ECM. However,
non-treated IFPSCs displayed a weak staining for the chondrogenic
marker collagen II [Fig. 5(B, E and H)].
In addition, differential expression of selected chondrogenic key
markers was evaluated by RT-PCR [Fig. 5(F)]. After 14 days, extract-
treated cells showed increased gene expression for Col2A1, Acan,
Col10, L-Sox5, Sox6 and Sox9, in comparison with control IFPSCs,
which showed a low expression for Acan and L-Sox5 and a weak
expression for Col2A1, ColX, and Sox6. Chondrocytes exhibited
higher expression levels of these genes than exposed cells. No
signiﬁcant changes were observed in the expression of Col1 in all
samples. Interestingly, extract not exposed cells showed a basal
expression for Col2A1, Sox9, Acan, Sox6 and ColX.
Cell attachment and distribution in the scaffold
Chondrocytes, extract exposed cells and control cells were
seeded in the cylindrical scaffold for 5 days and outside and insidelayers of each scaffold were examined by ESEM [Fig. (6)]. All cells
were able to attach on the polymer surface by ﬁlopodia and con-
nected with each other. Chondrocytes acquired a predominantly
spherical or sometimes fusiform andwere surroundedwith a dense
matrix that extended between the cells to form a continuous
network of cell and matrix [Fig. 6(A and B)]. In contrast, control
non-exposed IFPSCs showed a ﬂattened morphology with a high
number of prolongations and secrete some dense material
[Fig. 6(C)]. Moreover, the cross-section images clearly showed that
these control cells were able to penetratewithin scaffold [Fig. 6(D)].
Interestingly, extract exposed IFPSCs were able to grow covering
the scaffold pores and to secrete a high dense extracellular matrix
(ECM) that formed a homogeneously compact surface [Fig. 6(E and
F)]. Furthermore, histological and immunohistochemical analyses
of scaffold sections clearly showed cartilage-speciﬁc extracellular
components produced by the IFPSCs exposed to the extract (Fig. 7).
Discussion
Mature hyaline cartilage has a very low self-repair potential due
to its intrinsic properties. For this reason, researchers have focus in
the search of methods to induce complete cartilage repair. In the
last years, tissue engineering strategies combining cell therapy and
scaffolds have emerged as a promising new approach for the
treatment of articular cartilage defects24,25.
Fig. 4. Morphological analysis of control IFPSCs (permeabilized but not exposed to extract cells) and extract exposed cells. Phase-contrast light microscopy of chondrocytes (A),
control IFPSCs (B) and extracts-treated IFPSCs (C). GAG synthesized was visualized by toluidine blue staining in chondrocytes (D) and in IFPSCs under chondrogenic differentiation
(F), but not in control cells (E). TEM analysis of chondrocytes (G and J) showing a cytoplasm containing abundant RER, LI, proteoglycan granules and a homogeneous distribution of
FC. Control IFPSCs with their complement of cytoplasmic organelles, such as RER, GA and vacuoles (H and K). Finally, IFPSCs exposed to the extract showed rounded-shaped lipid
vesicles and proteoglycan granules in both cytoplasm and ECM (I and L). Original magniﬁcation 20 for AeF.
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differentiated cells can be transdifferentiated in other differentiated
cell types or dedifferentiated into pluripotent cells17,19. Moreover,
we have demonstrated that using extracts from adult human heart
tissue MSCs induced differentiation toward cardiomyocytes26.
Recently, it has been shown that IFPSCs undergo chondrocyte
differentiation, do not seem to have any age related decline in
proliferative potential and are easily accessible with less discomfort
to the patients27,28. In this work we analyze the chondrogenic
potential of MSCs obtained from Hoffa’s fat pad of patients with OAafter the exposition to an extract, containing the intracellular
components of chondrocytes.
We observed that human articular chondrocytes obtained from
elderly patients maintained a chondrocyte phenotype in agreement
with29. Chondrocytes and IFPSCs characterization by ﬂow cytometry
showed similar expression of MSCs surface makers CD90, CD105 and
CD73. CD90 has been suggested as a new target to induce re-
differentiation of dedifferentiated human chondrocytes in cartilage
regeneration procedures and CD105 could be used as a molecular
marker predictive of the capacity of cultured chondrocytes to form
Fig. 5. Immunoﬂuorescence of collagen II and gene expression of chondrogenic markers. Type II collagen indirect immunoﬂuorescence of chondrocytes (A, D and G), control IFPSCs
(B, E and H) and IFPSCs exposed to the extract (C, F and I). Expression of cartilage-speciﬁc collagen II protein with intense green staining can be appreciated on treated cells, showing
the characteristic collagen ﬁbers framework of cartilage. Original magniﬁcation 63 for A and GeI; 10 for B; 20 for C; 40 for DeF. RT-PCR analysis of chondrogenic markers (F).
Two weeks in culture chondrocytes used as positive control (lane 3) and extracts-exposed IFPSCs (lane 1) showed increased gene expression for Col2A1, Acan, Col10, L-Sox5, Sox6 and
Sox9. Basal expression of these genes was seen in control IFPSCs (lane 2). Expression of Gapdh was used as an internal control. Experiments were performed in triplicate, were
carried out at least twice and yielded similar results.
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Fig. 6. Scanning electron micrograph of human of chondrocytes (A and B), control IFPSCs (C and D) and extracts-treated IFPSCs (E and F) after 5 days growing on the PLGA scaffold.
Numerous cells ﬁrmly adhere to the scaffold and appeared to be suspended within the lumen or crawled around the walls. Chondrocytes show a round shaped morphology and
a rough surface. Chondrocytes and extracts-treated IFPSCs appeared surrounded by matrix.
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drocytes, and showed a basal expression in IFPSCs. In fact, mature
articular joint develops from embryonicmesodermal precursors that
differentiate into chondroprogenitors and ultimately into mature
adult chondrocytes31. In addition, we found that IFPSCs were able to
differentiate into speciﬁc lineages suggesting that fat pad cell pop-
ulation, as shown previously even in OA, contains a population of
highly proliferative and multipotent MSCs32.
IFPSCs exposed to chondrocyte extracts showed characteristic
morphological changes suggesting the acquisition of a chon-
drocyte-like cell phenotype that was conﬁrmed by the increased
proteoglycan formation33 in both toluidine staining and TEM
observations, in agreement with chondrocytes typical features34.
Further studies to demonstrate if the chondrocyte extract induce
modiﬁcations in the expression of adipogenic and/or osteogenic
markers will be of interest.Collagen type II, a marker for hyaline cartilage together with
aggrecan, are the predominant proteins in the ECM of cartilage35.
Immunostaining of extracts-treated IFPSCs showed an increased
expression of collagen II. Similarly, PCR analysis displayed an up-
regulation of Col2a1 and others chondrocyte-marker genes
including Sox9, L-Sox5 and Acan. Sox9 is the master transcription
factor for chondrogenesis, which acts in early stages of chondrocyte
differentiation by directly induction of type II collagen36 and is
expressed in the mesenchymal condensations37. Moreover, it has
been previously demonstrated that Sox9 in concert with L-Sox5 and
Sox6, regulates cartilage formation and maintains the chondrocyte
phenotype in the mature cartilage by activating expression of
several cartilage-speciﬁc genes, including genes Col2a1, Col9a1 and
Col11a1, Acan and Comp38. In treated IFPSCs Sox9 and its cofactor L-
sox5 expressions were elevated and a slightly induction of Sox6was
found.
Fig. 7. Analysis for cartilage-speciﬁc extracellular components of PLGA scaffolds sections seeded with transdifferentiated IFPSCs. Safranin O staining (A and B) and toluidine blue
staining (C and D) revealing GAGs production. Indirect immunoﬂuorescence visualized in green for cartilage-speciﬁc collagen II protein (E and F). 5 original magniﬁcation for: A, C,
E; 10 original magniﬁcation for: B and D; 20 F.
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markers such as collagen X with a concomitant decrease in the
synthesis of type II collagen and aggrecan39. In our study chon-
drocytes isolated from patients with OA showed increased Col10
expression, however IFPSCs exposed to the extract displayed
a marked reduction. This fact together with the increased expres-
sion of Sox9, L-Sox5, Sox6 and Col2a1, suggest the efﬁcacy of this
methodology to promote mature chondrogenesis. Nevertheless,
the use of Col10mRNA as amarker of chondrogenic hypertrophy for
in vitro studies has been questioned40.
Type I collagen is categorized as a ﬁbril-forming collagen and
is usually produced when cells go into ﬁbroblastic or osteoblastic
differentiation41. In our experiment, Col1a1 transcripts were
constitutively expressed in chondrocytes and IFPSCs. After expo-
sure to the extracts this expression was not affected. Type I
collagen participates in regulating mesenchymal condensation
and the onset of chondrogenic differentiation42. Moreover, Col1
expression increase has been often closely related to chondro-
genic differentiation in vitro43. The basal expression of charac-
teristic chondrogenic markers in IFPSCs can be explained
according to their micro-environmental niche. Recently, it has
been demonstrated that non-cartilaginous knee joint tissues such
as IFP possess signiﬁcant chondrogenic potentials and this may be
associated with the proximity to the niche they reside31,44,45. In
addition, IFPSCs offer number of practical advantages such as they
can be extracted from the same patient, avoiding rejection or side
effects of immunosuppressive medication administration. More-
over, they are easily accessible, with less discomfort to the
patient, as they can be obtained from osteoarthritic knee during
knee arthroscopy. Furthermore, the fat pad has a greater yield of
MSCs than bone marrow46,47.
It has been shown that in comparison with monolayer 3-D
matrices, which are developed to mimic the extracellular envi-
ronment, could maintain better chondrocyte phenotypes and play
a critical role in supporting chondrogenesis24,48. Therefore, we
growth transdifferentiated IFPSCs in 3-D PLGA scaffolds, a cylin-
drical implant constructed with a porous cartilage phase which
have been used before as cell-free for cartilage repair in surgery49.
Nano-structured PLGA surfaces have been shown to accelerate
chondrocyte adhesion and proliferation, as well as ECM produc-
tion50. Our results showed that 3D PLGA scaffold was able to
support growth and cell expansion and facilitate their free diffusion
throughout the structure. These preliminary results demonstrated
the afﬁnity of IFPSCs for PLGA-based scaffolds and its ability to
support chondrogenic differentiation.
Transdifferentiation studies have supported the notion that cell
fate is controlled by master switch genes and that one or two
factors can be sufﬁcient to direct cells fromone lineage to another51.
Transdifferentation of the IFPSCs into chondrocytes can involve
both the suppression and regulation of different genes in the cells,
implying that genes from both cell types are co-expressed at some
point. Further studies are necessaries to identify the factors and
molecules presents in the extract that should enhance our under-
standing of the mechanisms involved in chondrocyte differentia-
tion and development.
In conclusion, our results conﬁrmed that extracts obtained from
chondrocytes of osteoarthritic knees promote chondrogenic
differentiation of IFPSCs. This chondrogenesis was not depended of
exogenous growth factor induction, neither of the use of viral
vectors. To our knowledge there have not been done experiments of
IFPSCs programmed differentiation into chondrocytes using this
methodology. Moreover, we show here, for the ﬁrst time, that
combination of transdifferentiated IFPSCs with biodegradable 3D
PLGA scaffolds can serve as an efﬁcient system for the maintenance
and maturation of cartilage tissue. These ﬁndings encourage in vivoimplantation studies to corroborate its usefulness to repair articular
surface in OA.
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